Biomerica Stock Today
| BMRA Stock | USD 0.32 0.02 5.88% |
Performance0 of 100
| Odds Of DistressOver 72
|
Biomerica is trading at 0.32 as of the 22nd of November 2024, a 5.88 percent decrease since the beginning of the trading day. The stock's open price was 0.34. Biomerica has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Biomerica are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of November 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 3rd of January 2005 | Category Healthcare | Classification Health Care |
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection andor treatment of medical conditions and diseases worldwide. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California. The company has 16.82 M outstanding shares of which 562.41 K shares are currently shorted by private and institutional investors with about 2.28 trading days to cover. More on Biomerica
Moving against Biomerica Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Biomerica Stock Highlights
| Chairman, CEO and Pres | Zackary Irani | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsBiomerica can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Biomerica's financial leverage. It provides some insight into what part of Biomerica's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biomerica (BMRA) is traded on NASDAQ Exchange in USA. It is located in 17571 Von Karman Avenue, Irvine, CA, United States, 92614 and employs 64 people. Biomerica is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.46 M. Biomerica conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 16.82 M outstanding shares of which 562.41 K shares are currently shorted by private and institutional investors with about 2.28 trading days to cover.
Biomerica currently holds about 6.08 M in cash with (5.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Biomerica Probability Of Bankruptcy
Ownership AllocationBiomerica holds a total of 16.82 Million outstanding shares. Biomerica shows 7.22 percent of its outstanding shares held by insiders and 13.01 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Biomerica Ownership Details
Biomerica Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Goss Wealth Management Llc | 2024-06-30 | 32.7 K | |
| Jane Street Group Llc | 2024-06-30 | 28 K | |
| Heritage Investors Management Corp | 2024-09-30 | 21 K | |
| Northern Trust Corp | 2024-09-30 | 20.7 K | |
| Penn Capital Management Company Llc | 2024-09-30 | 20.6 K | |
| Two Sigma Securities, Llc | 2024-06-30 | 18.9 K | |
| Raymond James Finl Svs Advisors, Inc. | 2024-09-30 | 14.5 K | |
| Hollencrest Securities, Llc | 2024-06-30 | 11.6 K | |
| Wells Fargo & Co | 2024-06-30 | 6.6 K | |
| Granahan Investment Management Inc.. | 2024-06-30 | 860.5 K | |
| Acadian Asset Management Llc | 2024-06-30 | 226.1 K |
Biomerica Historical Income Statement
Biomerica Stock Against Markets
Biomerica Corporate Management
| Hans Boehringer | VP RD | Profile | |
| Steven Sloan | CFO Treasurer | Profile | |
| Lucy Liu | Director Operations | Profile | |
| Robert Carlson | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomerica. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Biomerica Stock refer to our How to Trade Biomerica Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biomerica. If investors know Biomerica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biomerica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.37) | Revenue Per Share 0.327 | Quarterly Revenue Growth 0.055 | Return On Assets (0.39) | Return On Equity (0.76) |
The market value of Biomerica is measured differently than its book value, which is the value of Biomerica that is recorded on the company's balance sheet. Investors also form their own opinion of Biomerica's value that differs from its market value or its book value, called intrinsic value, which is Biomerica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biomerica's market value can be influenced by many factors that don't directly affect Biomerica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biomerica's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biomerica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biomerica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.